跳至主要内容
临床试验/IRCT2016052428037N1
IRCT2016052428037N1已完成2 期

Reduction of steroid inhaler dose in comparison with Montelucast discontinuation in asthma patients controlled by steroid inhaler and Montelucast

Dr.Abidi Pharmaceutical Company0 个研究点目标入组 60 人开始时间: 待定最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
发起方
入组人数
60

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 no limit(—)
性别
All

入选标准

  • Inclusion Criteria:
  • 1: Asthmatic patients with Asthma Control Test (ACT) >20 and FEV1> 80% predicted in two sequential visits
  • 2: Age >18 years old
  • 3.Asthma symptoms>1 year
  • 4: Use of asthma controller medications >3 months
  • 5: At least 2 monthly visits by his/her physician in Imam Khomeini pulmonary clinic

排除标准

  • 1: Use of systemic steroids or emergency visit in the past 3 months due to asthma exacerbation
  • 2: Pregnancy
  • 3: Inability or unwillingness for scheduled visits by his/her physician
  • 4: Patients request for increase in the asthma medication after enrolling in this study

研究者

发起方
Dr.Abidi Pharmaceutical Company

相似试验

Comparison of two methods of asthma medication... | 临床试验